Stoke Therapeutics
STOK
24.29
-0.08
-0.33%
Stoke Therapeutics
US · STOK
#2942 by market cap
Listed 2019
24.29
-0.08
-0.33%
Live - 5344 symbols - heartbeat 422s ago
· 2026-10-07 19:54
After-hours
24.29
0.00%
- Market cap
- 1.57B
- P/E (TTM)i
- -7.25
- P/Bi
- 4.54
- EPSi
- -0.12
- Div yieldi
- 0.00%
- 52W posi
- 20%
Reader sentiment
Are you bullish or bearish on STOK?
Anonymous reader poll. Unscientific, not investment advice.
About Stoke Therapeutics
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.
- Founded
- 2014
- CEO
- Mr. Ian F. Smith
- Employees
- 170
- Headquarters
- Bedford, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- stoketherapeutics.com
Company profile
- Exchange
- US
- Symbol
- STOK
- Market-cap rank
- #2942
- Listing date
- 2019-06-19
- Market cap
- 1.57B
- Float cap
- 1.11B
- Shares out
- 64.53M
- Float shares
- 45.61M
Sectors & themes
Biotechnology
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.